| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of clinafloxacin, trovafloxacin, quinupristin/dalfopristin, and other antimicrobial agents versus Staphylococcus aureus isolates with reduced susceptibility to vancomycin
|
Cohen, Michael A
|
|
1999
|
33 |
1 |
p. 43-46
4 p.
|
artikel
|
| 2 |
Antimicrobial activity of SCH27899 (Ziracin®), a novel everninomicin derivative, tested against Streptococcus spp.: disk diffusion/Etest method evaluations and quality control guidelines
|
Marshall, Steven A.
|
|
1999
|
33 |
1 |
p. 19-25
7 p.
|
artikel
|
| 3 |
Characterization of the inoculum effect with Haemophilus influenzae and β-lactams
|
Balko, Tamara
|
|
1999
|
33 |
1 |
p. 47-58
12 p.
|
artikel
|
| 4 |
Comparison of ex-vivo serum bactericidal activity of cefepime, ceftazidime and cloxacillin against Staphylococcus aureus
|
Dan, Michael
|
|
1999
|
33 |
1 |
p. 39-42
4 p.
|
artikel
|
| 5 |
Encapsulated Enterococcus faecalis: role of encapsulation in persistence in mouse peritoneum in absence of mouse lethality
|
Bottone, Edward J
|
|
1999
|
33 |
1 |
p. 65-68
4 p.
|
artikel
|
| 6 |
In vitro activity of SCH 27899 (Ziracin) against Legionella species
|
Edelstein, PaulH
|
|
1999
|
33 |
1 |
p. 59-62
4 p.
|
artikel
|
| 7 |
In vitro activity of the new quinolone moxifloxacin (Bay 12-8039) against resistant gram-positive clinical isolates
|
Alcalá, Luis
|
|
1999
|
33 |
1 |
p. 27-31
5 p.
|
artikel
|
| 8 |
In vitro activity of trovafloxacin against ciprofloxacin-susceptible and -resistant clinical bacterial isolates and assessment of the trovafloxacin disk test
|
Fuchs, Peter C
|
|
1999
|
33 |
1 |
p. 33-38
6 p.
|
artikel
|
| 9 |
In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B
|
Abraham, O.C
|
|
1999
|
33 |
1 |
p. 7-11
5 p.
|
artikel
|
| 10 |
IS6110 dot blot hybridization for the identification of Mycobacterium tuberculosis complex
|
Kam, Kai Man
|
|
1999
|
33 |
1 |
p. 13-18
6 p.
|
artikel
|
| 11 |
The detection of positive blood cultures by the AccuMed ESP-384 system: the clinical significance of three-day testing
|
Han, XiangY
|
|
1999
|
33 |
1 |
p. 1-6
6 p.
|
artikel
|
| 12 |
Vibrio cholerae O1 serotype Ogawa in a neonate
|
Uppal, Beena
|
|
1999
|
33 |
1 |
p. 63-64
2 p.
|
artikel
|
Tijdschrift beschrijving